Table 2.

The association of body mass index, Adult Treatment Panel-III components and metabolic status (1991–93) with cardiovascular disease and type 2 diabetes over the follow-up (until 2007–09)

	CVD HR (95% CI) (n = 828)	Type 2 diabetes HR (95% CI) (n = 798)
Body mass index
Normal weight	1.0 (ref)	1.0
Overweight	1.36 (1.17–1.57)	1.75 (1.49–2.05)
Obese	1.89 (1.51–2.37)	3.90 (3.19–4.76)
ATP-III components
Blood pressure ≥130/85 mmHg or medication	1.74 (1.51–2.00)	1.60 (1.39–1.85)
Triglycerides ≥1.7 mmol/L or medication	1.66 (1.44–1.91)	2.51 (2.17–2.90)
HDL-cholesterol <1.03 (<1.29) mmol/L (women)	1.68 (1.44–1.97)	2.15 (1.84–2.51)
Fasting glucose ≥5.6 mmol/L or medication	1.25 (1.06–1.47)	2.64 (2.27–3.06)
Metabolic status (defined using ATP-III criteria)
Healthy	1.0	1.0
Unhealthy	1.97 (1.72–2.27)	3.22 (2.79–3.73)

Analyses adjusted for sex, socioeconomic status, marital status, ethnicity physical activity, smoking, alcohol, fruits and vegetables consumption, CVD medication and procedures.

HR, hazard ratio; CI, confidence interval.